4 completed, 1 active not recruiting, 1 unknown. 2 Phase 2, 2 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 3 | 2 | Active not recruiting 1, Unknown 1 |
| Phase 1 | 1 | Completed 1 |
Follow Post COVID-19 Condition, Unspecified: new trials by email Literature Review of Post COVID-19 Condition, Unspecified trials Research Report on Post COVID-19 Condition, Unspecified
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Treatment of Post-COVID-19 With Hyperbaric Oxygen Therapy: a Randomized, Controlled Trial Hyperbaric oxygen - Post-COVID-19 Syndrome, Post-COVID Syndrome | Phase 3 | Unknown | Erasmus Medical Center | 120 | 2024-10-01 | 2024-02-28 |
| PAxlovid loNg cOvid-19 pRevention triAl With recruitMent In the Community in Norway Nirmatrelvir/ritonavir, Placebo - Post COVID-19 Condition, Unspecified, SARS-CoV2 Infection | Phase 3 | Active not recruiting | Haukeland University Hospital | 2000 | 2023-05-12 | 2025-11-21 |
| ImPROving Quality of LIFe in the Long COVID Patient Nirmatrelvir/ritonavir, Placebo/ritonavir - Post-COVID-19 Syndrome, Long COVID | Phase 2 | Completed | Karolinska Institutet | 219 | 2023-05-01 | 2024-12-04 |
| Dual Sympathetic Blocks for Patients Experiencing Sympathetically-Mediated Symptoms From Long COVID stellate ganglion block with 0.5% bupivacaine - Post Acute COVID-19 Syndrome, Long COVID | Phase 1 | Completed | Jonathann Kuo, MD | 20 | 2023-01-03 | 2025-03-13 |
| Safety and Efficacy of Hyperbaric Oxygen Therapy for Long COVID Syndrome Hyperbaric oxygen, Sham treatment - COVID-19, Post COVID-19 Condition | Phase 2 | Completed | Karolinska University Hospital | 80 | 2021-09-15 | 2024-08-22 |
| Post-COVID-19 Mucormycosis in Critical Care Mucormycosis; Rhinocerebral (Etiology), Post COVID-19 Condition, Unspecified | Completed | Zagazig University | 150 | 2021-05-01 | 2023-06-20 |
COVID-19 (4) · Post-Acute COVID-19 Syndrome (4) · Autonomic Nervous System Diseases (1) · Dysautonomia like disorder (1) · Eye Infections (1) · Mucormycosis (1) · Post-Infectious Disorders (1) · Postural Orthostatic Tachycardia Syndrome (1) · Shy-Drager Syndrome (1) · Sinusitis (1)
Infections (6) · Respiratory Tract Diseases (6) · Respiratory Tract Infections (6) · Coronaviridae Infections (5) · Coronavirus Infections (5) · Lung Diseases (5) · Nidovirales Infections (5) · Pneumonia (5) · Pneumonia, Viral (5) · RNA Virus Infections (5) · Virus Diseases (5) · Chronic Disease (4) · Disease Attributes (4) · Pathologic Processes (4) · Pathological Conditions, Signs and Symptoms (4)
Hyperbaric Oxygenation (2) · nirmatrelvir and ritonavir drug combination (2) · Bupivacaine (1) · Ritonavir (1)
Erasmus Medical Center (1) · Haukeland University Hospital (1) · Jonathann Kuo, MD (1) · Karolinska Institutet (1) · Karolinska University Hospital (1) · Zagazig University (1)
Sweden (2) · Egypt (1) · Netherlands (1) · Norway (1) · United States (1)
Michael Runold, MD, PhD (2) · Anders Kjellberg, MD, PhD (1) · Ayman Sadek, MD (1) · Jonathann Kuo, MD (1) · Judith Bruchfeld, MD, PhD (1) · Malin Nygren-Bonnier, PhD (1) · Nina Langeland, MD, PhD (1) · Peter Lindholm, MD, PhD (1)